is wegovy a glp-1 drug Pill Wins FDA Approval as First Oral Treatment for Obesity and Weight Loss GLP-1 Drug Can Cause Rare,
Description
Double power: CagriSema Novo Nordisks CagriSema builds on the success of semaglutide by combining it with an amylin analogue (amylin helps manage blood sugar)

The cardioprotective effects of GLP-1RAs include anti-inflammatory actions, reduction of myocardial ischemia injury, modifications in the synthesis and secretion of lipids, and improvement of endothelial dysfunction (109)

Mo1908: glucagon-like peptide-1 receptor agonist use in patients with perianal fistulizing Crohns disease is well tolerated and leads to weight loss and clinical improvement in fistula activity

doi: 10.1016/j.celrep.2017.10.008 [DOI] [PubMed] [Google Scholar] 47

J Fam Pract
It is not widely prescribed
